PL366301A1 - Neurotrophic tacrolimus analogs - Google Patents
Neurotrophic tacrolimus analogsInfo
- Publication number
- PL366301A1 PL366301A1 PL01366301A PL36630101A PL366301A1 PL 366301 A1 PL366301 A1 PL 366301A1 PL 01366301 A PL01366301 A PL 01366301A PL 36630101 A PL36630101 A PL 36630101A PL 366301 A1 PL366301 A1 PL 366301A1
- Authority
- PL
- Poland
- Prior art keywords
- neurotrophic
- tacrolimus analogs
- tacrolimus
- analogs
- neurotrophic tacrolimus
- Prior art date
Links
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical class C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 title 1
- 230000000508 neurotrophic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25850000P | 2000-12-29 | 2000-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL366301A1 true PL366301A1 (en) | 2005-01-24 |
Family
ID=22980816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01366301A PL366301A1 (en) | 2000-12-29 | 2001-12-31 | Neurotrophic tacrolimus analogs |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1353671A4 (es) |
| JP (1) | JP2004527472A (es) |
| KR (2) | KR20070030331A (es) |
| CN (1) | CN1293877C (es) |
| AR (1) | AR035411A1 (es) |
| AU (1) | AU2002231277B2 (es) |
| BR (1) | BR0116762A (es) |
| CA (1) | CA2433384A1 (es) |
| CZ (1) | CZ20032060A3 (es) |
| HU (1) | HUP0302521A3 (es) |
| IL (1) | IL156664A0 (es) |
| MX (1) | MXPA03005941A (es) |
| NO (1) | NO20032913D0 (es) |
| NZ (1) | NZ527209A (es) |
| PL (1) | PL366301A1 (es) |
| RU (1) | RU2288716C2 (es) |
| WO (1) | WO2002053159A1 (es) |
| ZA (1) | ZA200305806B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003901023A0 (en) * | 2003-03-04 | 2003-03-20 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| EP1706117A1 (en) * | 2004-01-20 | 2006-10-04 | Astellas Pharma Inc. | Method for treating erectile dysfunction |
| EP1810675A1 (en) * | 2006-01-18 | 2007-07-25 | Institut Curie | Method for treating Huntington's disease by inhibiting dephosphorylation of huntingtin at S421 |
| JP2009102226A (ja) * | 2006-02-14 | 2009-05-14 | Meiji Milk Prod Co Ltd | 脊髄損傷治療剤 |
| BRPI0916232A2 (pt) * | 2008-07-23 | 2017-08-29 | Novartis Ag | Moduladores do receptor de esfingosina-1-fosfato e seu uso para tratar inflamação muscular |
| EP2817009A1 (en) * | 2012-02-23 | 2014-12-31 | INSERM - Institut National de la Santé et de la Recherche Médicale | Calcineurin inhibitors for use in the treatment of lesional vestibular disorders |
| GB201309375D0 (en) * | 2013-05-24 | 2013-07-10 | Chronos Therapeutics Ltd | Medical methods and compounds for medical use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US537663A (en) * | 1895-04-16 | wubstee | ||
| ES2071681T3 (es) * | 1987-12-09 | 1995-07-01 | Fisons Plc | Compuestos macrociclicos. |
| GR1001225B (el) * | 1989-09-14 | 1993-06-30 | Fisons Plc | Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους. |
| US5534520A (en) * | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
| US5541193A (en) * | 1991-09-05 | 1996-07-30 | Abbott Laboratories | Heterocycle-containing macrocyclic immunomodulators |
| GB9202196D0 (en) * | 1992-02-01 | 1992-03-18 | Fisons Plc | Method of treatment |
| GB9218027D0 (en) * | 1992-08-25 | 1992-10-14 | Fisons Plc | Novel method of treatment |
| US5696135A (en) * | 1995-06-07 | 1997-12-09 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
| US5968921A (en) * | 1997-10-24 | 1999-10-19 | Orgegon Health Sciences University | Compositions and methods for promoting nerve regeneration |
| GB9917158D0 (en) * | 1999-07-21 | 1999-09-22 | Fujisawa Pharmaceutical Co | New use |
-
2001
- 2001-12-27 AR ARP010106058A patent/AR035411A1/es unknown
- 2001-12-31 PL PL01366301A patent/PL366301A1/xx not_active Application Discontinuation
- 2001-12-31 WO PCT/US2001/050419 patent/WO2002053159A1/en not_active Ceased
- 2001-12-31 NZ NZ527209A patent/NZ527209A/en unknown
- 2001-12-31 CN CNB018228860A patent/CN1293877C/zh not_active Expired - Fee Related
- 2001-12-31 KR KR1020077003889A patent/KR20070030331A/ko not_active Ceased
- 2001-12-31 IL IL15666401A patent/IL156664A0/xx unknown
- 2001-12-31 RU RU2003123493/15A patent/RU2288716C2/ru not_active IP Right Cessation
- 2001-12-31 EP EP01991558A patent/EP1353671A4/en not_active Withdrawn
- 2001-12-31 BR BR0116762-6A patent/BR0116762A/pt not_active Application Discontinuation
- 2001-12-31 CA CA002433384A patent/CA2433384A1/en not_active Abandoned
- 2001-12-31 AU AU2002231277A patent/AU2002231277B2/en not_active Ceased
- 2001-12-31 KR KR1020037008787A patent/KR100794204B1/ko not_active Expired - Fee Related
- 2001-12-31 HU HU0302521A patent/HUP0302521A3/hu unknown
- 2001-12-31 CZ CZ20032060A patent/CZ20032060A3/cs unknown
- 2001-12-31 MX MXPA03005941A patent/MXPA03005941A/es active IP Right Grant
- 2001-12-31 JP JP2002554109A patent/JP2004527472A/ja not_active Ceased
-
2003
- 2003-06-24 NO NO20032913A patent/NO20032913D0/no not_active Application Discontinuation
- 2003-07-28 ZA ZA2003/05806A patent/ZA200305806B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100794204B1 (ko) | 2008-01-14 |
| NO20032913D0 (no) | 2003-06-24 |
| IL156664A0 (en) | 2004-01-04 |
| CZ20032060A3 (cs) | 2004-01-14 |
| BR0116762A (pt) | 2004-08-10 |
| NZ527209A (en) | 2005-09-30 |
| RU2288716C2 (ru) | 2006-12-10 |
| RU2003123493A (ru) | 2005-01-20 |
| CA2433384A1 (en) | 2002-07-11 |
| EP1353671A4 (en) | 2004-07-14 |
| AU2002231277B2 (en) | 2006-11-30 |
| HUP0302521A2 (hu) | 2003-11-28 |
| CN1293877C (zh) | 2007-01-10 |
| WO2002053159A1 (en) | 2002-07-11 |
| ZA200305806B (en) | 2005-01-26 |
| AR035411A1 (es) | 2004-05-26 |
| HUP0302521A3 (en) | 2007-03-28 |
| EP1353671A1 (en) | 2003-10-22 |
| JP2004527472A (ja) | 2004-09-09 |
| MXPA03005941A (es) | 2005-02-14 |
| CN1538843A (zh) | 2004-10-20 |
| KR20040007431A (ko) | 2004-01-24 |
| KR20070030331A (ko) | 2007-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU145133S (en) | Rack | |
| AU4114201A (en) | Cyclic compounds | |
| GB0002847D0 (en) | Ampligier arrangement | |
| SG99909A1 (en) | Elevator | |
| CZ20011732A3 (cs) | Výtah | |
| AU2002360487A8 (en) | Acyclovir-peptide analogs | |
| TW478635U (en) | Building-block-assembled-type rack | |
| EG23909A (en) | Vatamin d, analogs | |
| AU146998S (en) | Rack | |
| IL158486A (en) | Nociceptin analogs | |
| EP1353671A4 (en) | NEUROTROPHIC TACROLIMUS ANALOGS | |
| AU146997S (en) | Rack | |
| HK1059891A (en) | Neurotrophic tacrolimus analogs | |
| GB0006193D0 (en) | Platforms | |
| AU9174501A (en) | Novel mitogen activated kinase | |
| TW428699U (en) | Lampstand structure | |
| SI1414828T1 (sl) | Protitumorski analogi | |
| TW561883U (en) | Structure for changing exercises | |
| AU141364S (en) | Rack | |
| TW444796U (en) | Bump-resistant structure for aid-lock | |
| TW485996U (en) | Multiple-functional movable floor structure | |
| GB0006388D0 (en) | Promoter | |
| TW459910U (en) | Combination structure for door-in-door | |
| GB0005151D0 (en) | None | |
| AU142390S (en) | Roof rack foot assembly |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |